May 5, 2020 / 11:20 AM / a month ago

BRIEF-Biocardia Announces Positive Preclinical Results Supporting Investigational New Drug Application For Anti-Inflammatory Cell Therapy In Heart Failure

BioCardia Inc:

* BIOCARDIA ANNOUNCES POSITIVE PRECLINICAL RESULTS SUPPORTING INVESTIGATIONAL NEW DRUG APPLICATION FOR ANTI-INFLAMMATORY CELL THERAPY IN HEART FAILURE

* BIOCARDIA - PLANNING FURTHER EXPLORATION & DISCUSSION WITH FDA ON USE OF ITS ALLOGENIC CELLS FOR COVID-19 RELATED ACUTE RESPIRATORY DISTRESS SYNDROME

* BIOCARDIA - INTENDS TO SUBMIT AN IND FOR USE OF ITS NK1R+ MSC DELIVERED VIA IV INFUSION FOR ARDS CAUSED BY COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below